Aura Biosciences, Inc. beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.41 | $-0.48 | -17.1% | Miss |
| Q12026 FY2026 | $-0.40 | $-0.50 | -25.0% | Miss |
| Q42025 FY2025 | $-0.43 | $-0.37 | +13.9% | Beat |
Back to AURA overview · AURA holders · AURA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.